Beclomethasone (BDP group) (N = 110) | Salbutamol (Placebo group) (N = 56) | |
---|---|---|
Male, n (%) | 64 (58.2) | 34 (60.7) |
Risk factors for asthma, n (%) | 57 (51.8) | 30 (53.6) |
Age, yr | 2.35 ± 0.81 | 2.29 ± 0.78 |
Weight, kg | 15.4 ± 2.82 | 14.9 ± 2.74 |
Height, cm | 97.5 ± 9.19 | 96.0 ± 9.61 |
Duration of wheezing, yr | 1.59 ± 0.87 | 1.43 ± 0.82 |
Symptom-free days, % | 21.4 ± 18.3 | 25.9 ± 21.0 |
Daily coughing score | 1.43 ± 0.71 | 1.35 ± 0.80 |
Daily Salbutamol use, na | 0.49 ± 0.48 | 0.42 ± 0.35 |